APA (7th ed.) Citation

Wang, Y., Cheng, Y., Guo, Y., Fan, Y., Zhou, R., Zhang, Q., . . . Hu, W. (2025). A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subjects. European journal of drug metabolism and pharmacokinetics, 50(3), 265-272. https://doi.org/10.1007/s13318-025-00944-5

Chicago Style (17th ed.) Citation

Wang, Ying, et al. "A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subjects." European Journal of Drug Metabolism and Pharmacokinetics 50, no. 3 (2025): 265-272. https://doi.org/10.1007/s13318-025-00944-5.

MLA (9th ed.) Citation

Wang, Ying, et al. "A Phase I Study to Evaluate the Relative Bioavailability, Pharmacodynamics, and Safety of a Single Subcutaneous Injection of Recaticimab at Three Different Sites in Healthy Chinese Subjects." European Journal of Drug Metabolism and Pharmacokinetics, vol. 50, no. 3, 2025, pp. 265-272, https://doi.org/10.1007/s13318-025-00944-5.